0000899243-17-018917.txt : 20170725
0000899243-17-018917.hdr.sgml : 20170725
20170725171255
ACCESSION NUMBER: 0000899243-17-018917
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170721
FILED AS OF DATE: 20170725
DATE AS OF CHANGE: 20170725
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fischer Laurent
CENTRAL INDEX KEY: 0001379344
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-28386
FILM NUMBER: 17981064
MAIL ADDRESS:
STREET 1: C/O PANACOS PHARMACEUTICALS, INC.
STREET 2: 134 COOLIDGE AVENUE
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CTI BIOPHARMA CORP
CENTRAL INDEX KEY: 0000891293
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 911533912
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3101 WESTERN AVENUE
STREET 2: SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 2062827100
MAIL ADDRESS:
STREET 1: 3101 WESTERN AVENUE
STREET 2: SUITE 600
CITY: SEATTLE
STATE: WA
ZIP: 98121
FORMER COMPANY:
FORMER CONFORMED NAME: CELL THERAPEUTICS INC
DATE OF NAME CHANGE: 19960321
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-07-21
0
0000891293
CTI BIOPHARMA CORP
CTIC
0001379344
Fischer Laurent
C/O CTI BIOPHARMA CORP.
3101 WESTERN AVE., SUITE 600
SEATTLE
WA
98121
1
0
0
0
Stock Option (Right to Buy)
3.41
2017-07-21
4
A
0
50000
0.00
A
2027-07-21
Common Stock
50000
50000
D
The stock options will vest on the first to occur of (1) July 21, 2018, (2) immediately prior to the first annual meeting of the Company's shareholders that occurs in 2018 and at which one or more members of the Board are to be elected, or (3) immediately prior to the occurrence of a Change in Control (as such term is defined in the 2017 Equity Incentive Plan), subject to Dr. Fischer's continued service through such date or event.
/s/ Bruce J. Seeley, Attorney-in-fact for Laurent Fischer
2017-07-25